- Home
- OPT vs KRUS Comparison
OPT vs KRUS Comparison
Compare OPT & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- KRUS
- Stock Information
- Founded
- OPT 1984
- KRUS 2008
- Country
- OPT Australia
- KRUS United States
- Employees
- OPT N/A
- KRUS N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- KRUS Restaurants
- Sector
- OPT Health Care
- KRUS Consumer Discretionary
- Exchange
- OPT Nasdaq
- KRUS Nasdaq
- Market Cap
- OPT 767.9M
- KRUS 915.2M
- IPO Year
- OPT 2020
- KRUS 2019
- Fundamental
- Price
- OPT $3.22
- KRUS $91.70
- Analyst Decision
- OPT Strong Buy
- KRUS Buy
- Analyst Count
- OPT 1
- KRUS 8
- Target Price
- OPT $12.00
- KRUS $84.88
- AVG Volume (30 Days)
- OPT 13.0K
- KRUS 107.7K
- Earning Date
- OPT 08-30-2024
- KRUS 01-02-2025
- Dividend Yield
- OPT N/A
- KRUS N/A
- EPS Growth
- OPT N/A
- KRUS N/A
- EPS
- OPT N/A
- KRUS N/A
- Revenue
- OPT $261,859.00
- KRUS $237,860,000.00
- Revenue This Year
- OPT N/A
- KRUS $19.90
- Revenue Next Year
- OPT $46,864.64
- KRUS $20.65
- P/E Ratio
- OPT N/A
- KRUS N/A
- Revenue Growth
- OPT N/A
- KRUS 26.91
- 52 Week Low
- OPT $1.79
- KRUS $48.66
- 52 Week High
- OPT $5.45
- KRUS $122.81
- Technical
- Relative Strength Index (RSI)
- OPT 40.67
- KRUS 40.69
- Support Level
- OPT $3.15
- KRUS $95.21
- Resistance Level
- OPT $3.78
- KRUS $101.32
- Average True Range (ATR)
- OPT 0.18
- KRUS 4.90
- MACD
- OPT -0.00
- KRUS -1.50
- Stochastic Oscillator
- OPT 25.91
- KRUS 0.78
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a Japanese restaurant company. It operates revolving sushi chain restaurants in the United States. It provides access to the revolving and express conveyor belts, on-demand ordering screen, plate slot, and the Bikkura-Pon rewards machine. The company offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, Salmon, among others. Geographically, it derives revenue from the United States of America.